Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for DSSTox_CID_2898

    Client Email Product

    DSSTox_CID_2898

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    22
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    6
    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    13
    API REF. PRICE (USD / KG)
    62,083

    API Market Place

    5
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    32
    Europe

    Europe

    64
    Canada

    Canada

    14
    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    9
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    10
    REF STANDARD

    EDQM

    2

    USP

    5

    JP

    0

    Other Listed Suppliers

    5
    SERVICES

    0

    left grey arrow
    right gray arrow
    • TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG
    Full View ScreenFull Screen View
    Health Canada Issues Recall of Apotex's Mirvala 28 tablets
    Health Canada Issues Recall of Apotex's Mirvala 28 tablets

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-apotexs-mirvala-28-tablets-1633945878.pdf

    Health Canada
    30 Sep 2021
    Share Share
    Health Canada Issues Recall of Aspen Pharmacare` Linessa 21
    Health Canada Issues Recall of Aspen Pharmacare` Linessa 21

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75877r-eng.php

    HEALTH CANADA
    22 Jun 2021
    Share Share
    Health Canada Issues Recall of Merck Canada Inc's Marvelon 21
    Health Canada Issues Recall of Merck Canada Inc's Marvelon 21

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-merck-canada-incs-marvelon-21-1587740273.pdf

    HEALTH CANADA
    24 Apr 2020
    Share Share
    Accord Healthcare's Generic Desogestrel; Ethinyl Estradiol Receives Approval US
    Accord Healthcare's Generic Desogestrel; Ethinyl Estradiol Receives Approval US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207067

    FDA
    14 Sep 2018
    Share Share
    Accord Hlthcare Generic Desogestrel; Ethinyl Estradiol Receives Approval In US
    Accord Hlthcare Generic Desogestrel; Ethinyl Estradiol Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209170

    FDA
    06 Jun 2017
    Share Share
    Aurobindo Pharma’s Generic Desogestrel; Ethinyl Estradiol Receives Approval In US
    Aurobindo Pharma’s Generic Desogestrel; Ethinyl Estradiol Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207081

    FDA
    18 May 2017
    Share Share
    Sandoz Inc Desogestrel: Ethinyl Estradiol Approved In US
    Sandoz Inc Desogestrel: Ethinyl Estradiol Approved In US

    https://www.pharmacompass.com/pdf/news/sandoz-inc-desogestrel-ethinyl-estradiol-approved-in-us-1474087536.pdf

    FDA
    09 Sep 2016
    Share Share
    Famy's Generic Desogestrel and Ethinyl Estradiol Approved in US For Contraception
    Famy's Generic Desogestrel and Ethinyl Estradiol Approved in US For Contraception

    https://www.pharmacompass.com/pdf/news/n72.pdf

    FDA
    22 May 2015
    Share Share
    Janssen Pharmaceuticals, Inc. Initiates Class II Recall of Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets
    Janssen Pharmaceuticals, Inc. Initiates Class II Recall of Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1063-2015&w=05202015&lang=eng

    FDA
    20 May 2015
    Share Share
    Recall: Ortho-Cept Tablets (28 DAY) (2015-04-24)
    Recall: Ortho-Cept Tablets (28 DAY) (2015-04-24)

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53137r-eng.php

    HEALTHY CANADIANS
    27 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Aspen Desogestrel

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search